SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 2,696.77 |
| Enterprise Value ($M) | 3,422.98 |
| Book Value ($M) | 3,146.17 |
| Book Value / Share | 14.52 |
| Price / Book | 0.86 |
| NCAV ($M) | -833.85 |
| NCAV / Share | -3.85 |
| Price / NCAV | -3.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.00 |
| Return on Assets (ROA) | 0.00 |
| Return on Equity (ROE) | 0.00 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.66 |
| Current Ratio | 3.82 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 602.47 |
| Assets | 4,582.49 |
| Liabilities | 1,436.32 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.04 | 2.57 | |
| 13G/A | Wasatch Advisors Inc | |||
| 13G/A | Norges Bank | 8.41 | -1.26 | |
| 13G/A | BlackRock Inc. | 11.50 | 1.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 531,216 | 1,826,985 | 29.08 | |
| 490,680 | 1,578,571 | 31.08 | |
| 250,705 | 699,446 | 35.84 | |
| 239,826 | 733,915 | 32.68 | |
| 526,833 | 575,690 | 91.51 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MTEX – Mannatech, Incorporated | MYGN – Myriad Genetics, Inc. |
| NBIX – Neurocrine Biosciences, Inc. | NKTX – Nkarta, Inc. |
| NMRA – Neumora Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io